Biolife Solutions (BLFS) Capital Expenditures (2010 - 2026)
Biolife Solutions (BLFS) posted quarterly Capital Expenditures of $167000.0 for Q1 2026, down 69.75% year-over-year from $552000.0 in Q1 2025, and down 96.08% quarter-over-quarter from $4.3 million in Q4 2025.
Biolife Solutions (BLFS) Capital Expenditures (2010 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has reported Capital Expenditures for 17 consecutive years, with $167000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Capital Expenditures fell 69.75% year-over-year to $167000.0; the TTM figure through Mar 2026 stood at $9.1 million (up 142.29% YoY), while the FY2025 annual figure was $9.5 million, up 193.71% from the prior year.
- Capital Expenditures retreated to $167000.0 in Q1 2026 per BLFS's latest filing, from $4.3 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $8.7 million in Q4 2022 and bottomed at -$2.5 million in Q2 2023.
- Historically, Capital Expenditures has averaged $1.7 million across 5 years, with a median of $762000.0 in 2024.
- On a YoY basis, Capital Expenditures climbed as much as 25246.15% in 2023 and fell as far as 2869.66% in 2023.
- Biolife Solutions' Capital Expenditures stood at $8.7 million in 2022, then sank by 73.44% to $2.3 million in 2023, then plunged by 67.11% to $762000.0 in 2024, then surged by 458.79% to $4.3 million in 2025, then tumbled by 96.08% to $167000.0 in 2026.
- Business Quant data shows BLFS's Capital Expenditures at $167000.0 in Q1 2026, $4.3 million in Q4 2025, and $5.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 112.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 143.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 374.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 51.13 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 111.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 43.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 83.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 86.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 116.00 Mn |
| 10 | Biolife Solutions | 1.82 Bn | 1.73 Bn | 18.29 Mn | 1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.04 Mn |
| Jun 30, 2026 | 1.04 Mn |
| Mar 31, 2026 | 167,000.00 |
| Mar 31, 2026 | 167,000.00 |
| Dec 31, 2025 | 4.26 Mn |
| Dec 31, 2025 | 4.26 Mn |
| Sep 30, 2025 | 5.13 Mn |
| Sep 30, 2025 | 5.13 Mn |
| Jun 30, 2025 | -462,000.00 |
| Jun 30, 2025 | -462,000.00 |
| Mar 31, 2025 | 552,000.00 |
| Mar 31, 2025 | 552,000.00 |
| Dec 31, 2024 | 762,000.00 |
| Dec 31, 2024 | 762,000.00 |
| Sep 30, 2024 | 2.16 Mn |
| Sep 30, 2024 | 2.16 Mn |
| Jun 30, 2024 | 276,000.00 |
| Jun 30, 2024 | 276,000.00 |
| Mar 31, 2024 | 26,000.00 |
| Mar 31, 2024 | 26,000.00 |